Sponsor study identifier
interventional
30
1 country
1
Study Start
January 24, 2025
Actual (reported)Primary Completion
April 20, 2025
Actual (reported)Study Completion
June 1, 2025
Actual (reported)the goal of the study was to evaluate the pain reduction and healing efficiency of traumatic oral ulcers in children using low-level laser therapy with diode laser 980 nm, lidocaine oral gel and chlorhexidine mouthwash
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 1, 2025
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 24, 2025
Actual (reported)April 20, 2025
Actual (reported)June 1, 2025
Actual (reported)August 16, 2025
Actual (reported)August 24, 2025
Actual (reported)Subjective pain assessment of the ulcer
evaluation of pain associated with the ulcer will be evaluated using visual analoque scale (VAS) before the onset of treatment then follow up of the degree of pain relief associated with treatment
2 weeks
Objective assessment of the ulcer size
2 weeks
Parental satisfaction
2 weeks
patients received low level laser therapy using diode laser 980 nm
patients were instructed to use Lidocaine gel (Oracure gel) 4 times daily.
patients were instructed to use Chlorhexidine mouthwash (Orovex) 4 times daily (control group).
patients received low level laser therapy using diode laser 980 nm with a low power
patients was instructed to use Lidocaine gel (Oracure gel) 4 times daily.
the National research Centre
Dokki, Giza Governorate, 12622, Egypt
Mansy ME, Rashed MF. Evaluation of low level laser therapy and lidocaine versus chlorohexidine for the management of traumatic oral ulcers in children: a randomized controlled study. Sci Rep. 2026 Jan 27;16(1):3738. doi: 10.1038/s41598-025-34529-8.
Maryam m El Mansy, researcher
The National Research Centre, Egypt
30 participants (actual enrollment reported by the registry).
First Submitted
August 16, 2025
First Posted
August 24, 2025
Study Start
January 24, 2025
patients was instructed to use Chlorhexidine mouthwash (Orovex) 4 times daily (control group).
Contact the study team to confirm eligibility.
Primary Completion
April 20, 2025
Actual (reported)Study Completion
June 1, 2025
Actual (reported)Last Updated
September 8, 2025
Record last verified: 2025-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: